CLOs on the Move

Meda Pharmaceuticals

www.medapharma.us

 
Meda is a leading international specialty pharma company with a broad product portfolio reaching more than 80% of the global pharmaceutical market. Sales at the end of 2014 amounted to more than SEK 15 billion (pro forma SEK 18.7 billion). Meda is thereby the 48th largest pharmaceutical company in the world. At the end of 2014 Meda had 5,202 (3,326) employees, 2,996 (2,009) of which worked in sales and marketing. The company’s main focus is sales and marketing and Meda has its own sales organizations in more than 60 countries. Sales and marketing activities are carried out via distributors in ...
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million
  • www.medapharma.us
  • 265 Davidson Ave Ste 300
    Somerset, NJ USA 08873
  • Phone: 732.564.2200

Executives

Name Title Contact Details

Similar Companies

Serve You

Serve You is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Midwest Eye Consultants

Midwest Eye Consultants provides total eye care from eye health exams to the treatment of eye diseases. See our locations page to find an office near you.

Kirby Cleaning

Do you work long hours or Just not enough hours in the day? Relief is just a phone call away. Get your life back, let me clean your home!

Amgenix International

Amgenix International is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oncopeptides

Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases. The company is focusing on the development of the lead product candidate melflufen, a first-in-class anti-cancer peptide-drug conjugate that rapidly delivers an alkylating payload into tumor cells. Melflufen is in development as a new treatment for the hematological cancer multiple myeloma and is currently being evaluated in multiple clinical studies including the pivotal phase 2 HORIZON study and the ongoing phase 3 OCEAN study. Oncopeptides` headquarters is in Stockholm, Sweden with U.S. headquarters in Boston, Mass. The company is listed in the Mid Cap segment on Nasdaq Stockholm with the ticker ONCO.